Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 6,300 shares, a decrease of 33.7% from the February 28th total of 9,500 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average […]
Related Keywords
Piper Sandler , Achilles Therapeutics Plc , Millennium Management , Renaissance Technologies , Forefront Analytics , Kettle Hill Capital Management , Nasdaq , Achilles Therapeutics , Get Rating , Hill Capital Management , Therapeutics Plc , Achilles Therapeutics Daily , Nasdaq Achl , Bachl , Medical , Stocks , Options , Put , Call ,
vimarsana.com © 2020. All Rights Reserved.